Sleep apnea is a serious life threatening problem that is known to greatly increase risks of heart attacks and strokes. Patients with untreated sleep apnea have up to a six fold increase in motor vehicle accidents, short term memory loss, problems with elevated blood pressure, increased insulin resistance and many other problems.
Michael Farrell is the global head of ResMed’s Sleep Business Unit. As a Senior Vice President of the second largest maker of CPAP his October 1,2009 announcement that it had acquired Laboratoires Narval (“Narval”) in Lyon. Narval is the French manufacturer and distributer of oral appliances for the treatment of sleep